EUVIMEDEUVIMED entdecken
Open Access

Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway

Yining Chen iD, Ping Shi, Suiqing Zhou, Kai Yu, Yulang Wang, Feifan Yao, Ruizhi Zhang, Xinyang Liu, Chunyao Fang, Xiaofeng Tie, Jun Li, Jing Xu und 2 weitere

Translational Gastroenterology and Hepatology · 2025-07 · 10 · 52-52

DOI: 10.21037/tgh-24-115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Gastroenterology and Hepatology, 2025-07. Verfasst von Yining Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CiprofolERKMAPKanti-tumourhepatocellular carcinoma (HCC)

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation (…
  • Department of Anesthesiology, the Fourth Affiliated Hospital of Zhejiang University, School of Medicine, Yiwu, China.
  • Department of Anesthesiology and Perioperative Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
  • Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

ORCID-Profile: Yining Chen, Xiongxiong Pan

Zitieren

APA

Chen, Y., Shi, P., Zhou, S., Yu, K., Wang, Y., Yao, F., Zhang, R., Liu, X., Fang, C., Tie, X., Li, J., Xu, J., Xu, J., & Pan, X. (2025). Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway. Translational Gastroenterology and Hepatology, 10, 52-52. https://doi.org/10.21037/tgh-24-115

Vancouver

Chen Y, Shi P, Zhou S, Yu K, Wang Y, Yao F, et al. Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway. Translational Gastroenterology and Hepatology. 2025;10:52-52. doi:10.21037/tgh-24-115

BibTeX
@article{Chen2025,
  author = {Chen, Yining and Shi, Ping and Zhou, Suiqing and Yu, Kai and Wang, Yulang and Yao, Feifan and Zhang, Ruizhi and Liu, Xinyang and Fang, Chunyao and Tie, Xiaofeng and Li, Jun and Xu, Jing and Xu, Jiali and Pan, Xiongxiong},
  title = {Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway},
  journal = {Translational Gastroenterology and Hepatology},
  year = {2025},
  volume = {10},
  pages = {52--52},
  doi = {10.21037/tgh-24-115}
}
Kostenlos starten →